Moleculin Biotech competitorsClear all

Moleculin Biotech's top competitors include Vivace Therapeutics, Provectus Biopharmaceuticals, Halozyme Therapeutics and Merrimack Pharmaceuticals.
Moleculin Biotech
Moleculin Biotech
Moleculin Biotech, Inc. is a pharmaceutical company focused on the development of anti-cancer drug candidates.
Vivace Therapeutics
Vivace Therapeutics
Vivace Therapeutics is a pharmaceutical company.
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics develops extracellular matrix targeting products for the insulin, cancer, dermatology and drug delivery markets.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Founding Date
Founding Date
2006
Founding Date
2014
Founding Date
2002
Founding Date
1998
Founding Date
2000
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Houston, US HQ
Locations
San Mateo, US HQ
Locations
Knoxville, US HQ
Brentwood, US
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Employees
Employees
9350% increase
Employees
614% decrease
Employees
2
Employees
13253% decrease
Employees
2763% decrease
Valuation ($)
Valuation ($)
52.5 m
Valuation ($)
N/A
Valuation ($)
26.7 m
Valuation ($)
5.5 b
Valuation ($)
51 m
Twitter followers
Twitter followers
828
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.1 k
Alexa Website Rank
Alexa Website Rank
267218
Alexa Website Rank
N/A
Alexa Website Rank
168926
Alexa Website Rank
361280
Alexa Website Rank
388656
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.2
Employee Rating
3

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$196m (FY, 2019)
Revenue (est.)
N/A
Net income
Net income
($13.2m) (FY, 2019)
Net income
N/A
Net income
($6.9m) (FY, 2019)
Net income
($72.2m) (FY, 2019)
Net income
($17.3m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 491k
Total funding raised
$ 40m
Total funding raised
N/A
Total funding raised
$ 113m
Total funding raised
$ 79.4m
For sources of this data, please see the company profile

View company profiles

Vivace Therapeutics
HQ
San Mateo, US
Employees
6↓ 14% decrease

Vivace Therapeutics is a pharmaceutical company.

View company
Provectus Biopharmaceuticals
HQ
Knoxville, US
Employees
2

Provectus Biopharmaceuticals, Inc., specializes in developing oncology and dermatology therapies.

View company
Halozyme Therapeutics
HQ
San Diego, US
Employees
132

Halozyme Therapeutics develops extracellular matrix targeting products for the insulin, cancer, dermatology and drug delivery markets.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company